Carisma Therapeutics【CARM】株式ニュース

名称	銘柄コード	市場	種別
Carisma Therapeutics Inc	CARM	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.01	0.73%	1.38	08:58:24

始値	安値	高値	終値	前日終値
1.42	1.35	1.42	1.41	1.37

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/16	20:30	PRNUS	Carisma Therapeutics Announces First Patient Dosed in Phase..
2024/5/09	20:52	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/09	20:41	EDGAR2	Form 8-K - Current report
2024/5/09	20:30	PRNUS	Carisma Therapeutics Reports First Quarter 2024 Financial..
2024/5/09	00:45	BW	Carmila: Withdrawal of funds for the liquidity contract
2024/5/08	20:30	PRNUS	Carisma Therapeutics Presents Preclinical Proof of Concept..
2024/5/08	00:45	BW	CARMILA: Information Concerning the Total Number of Voting..
2024/5/06	20:30	PRNUS	Carisma Therapeutics to Participate in The Citizens JMP Life..
2024/5/02	20:30	PRNUS	Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief..
2024/4/25	06:05	PRNUS	Carisma Therapeutics Announces Upcoming Presentation at the..
2024/4/25	01:43	BW	Carmila : Lancement d’un programme de rachat d’actions pour..
2024/4/23	05:35	PRNUS	Carisma Therapeutics to Present New Data at the American..
2024/4/18	00:45	BW	Carmila: First-quarter 2024 Financial Information
2024/4/06	00:45	BW	Carmila : Informations relatives au nombre total de droits..
2024/4/03	20:00	PRNUS	Carisma Therapeutics to Present at Upcoming Conferences
2024/4/01	21:35	PRNUS	Carisma Therapeutics Provides Business Update and Reports..
2024/4/01	20:00	PRNUS	Carisma Therapeutics Announces Changes to its Board of..
2024/3/22	06:00	PRNUS	Carisma Announces Upcoming Presentations at the American..
2024/3/16	01:45	BW	Carmila: Filing of the 2023 Universal Registration Document
2024/3/09	01:45	BW	CORRIGE ET REMPLACE : Carmila : Evolution de la composition..
2024/3/08	06:05	EDGAR2	Form SC 13D/A - General statement of acquisition of..
2024/3/08	03:13	BW	CARMILA: Changes in the composition of the Board of..
2024/3/05	01:45	BW	Carmila : Informations relatives au nombre total de droits..
2024/2/28	21:30	PRNUS	Carisma Therapeutics to Participate in TD Cowen's 44th..
2024/2/14	01:45	BW	Carmila: 2023 Annual Results
2024/2/03	06:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/03	03:06	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/03	01:45	BW	CARMILA: Information Concerning the Total Number of Voting..
2024/1/17	01:45	BW	Carmila: Resources Devoted to the Liquidity Contract as of..
2024/1/09	01:57	BW	CARMILA: Information Concerning the Total Number of Voting..
2023/12/21	21:00	PRNUS	Carisma Therapeutics to Present at the 42nd Annual J.P...
2023/12/14	21:00	PRNUS	First In Vivo CAR-M Lead Candidate Nominated Under..
2023/12/06	01:45	BW	Carmila : Informations relatives au nombre total de droits..
2023/11/28	21:00	PRNUS	Carisma Therapeutics Announces FDA Clearance of IND..
2023/11/22	21:30	PRNUS	Carisma Therapeutics to Participate in Evercore ISI..
2023/11/11	04:17	BW	Carmila: Termination of Liquidity Contract With BNP Paribas..
2023/11/10	01:45	BW	CARMILA : Informations relatives au nombre total de droits..
2023/11/09	22:36	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09	21:42	EDGAR2	Form 8-K - Current report
2023/11/09	21:30	PRNUS	Carisma Therapeutics Reports Third Quarter 2023 Financial..
2023/10/31	22:25	PRNUS	Carisma Presents Pre-Clinical Proof of Concept for in vivo..
2023/10/25	22:11	PRNUS	Carisma to Present First Results From in vivo CAR-M..
2023/10/21	00:47	BW	Carmila: Financial Information as of 30 September 2023
2023/10/03	01:35	BW	Carmila : Emission d’un emprunt obligataire de 500 millions..
2023/10/03	00:45	BW	CARMILA : Informations relatives au nombre total de droits..
2023/9/05	21:30	PRNUS	Carisma Therapeutics to Present at Upcoming Investor..
2023/9/02	00:45	BW	CARMILA : Informations relatives au nombre total de droits..
2023/9/01	22:05	EDGAR2	Form 8-K - Current report
2023/9/01	21:30	PRNUS	Carisma Announces Latest Data from Phase 1 Clinical Trial of..
2023/8/24	21:30	PRNUS	Carisma Therapeutics to Present at Upcoming Healthcare..